David Matheson
David Matheson
Verified email at wlv.ac.uk
Title
Cited by
Cited by
Year
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistageá…
ND James, MR Sydes, NW Clarke, MD Mason, DP Dearnaley, MR Spears, ...
The Lancet 387 (10024), 1163-1177, 2016
12792016
Abiraterone for prostate cancer not previously treated with hormone therapy
ND James, JS de Bono, MR Spears, NW Clarke, MD Mason, ...
New England Journal of Medicine 377 (4), 338-351, 2017
9612017
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
CC Parker, ND James, CD Brawley, NW Clarke, AP Hoyle, A Ali, ...
The Lancet 392 (10162), 2353-2366, 2018
4192018
STAMPEDE investigators. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptiveá…
ND James, MR Sydes, NW Clarke, MD Mason, DP Dearnaley, MR Spears, ...
Lancet 387 (10024), 1163-77, 2016
1372016
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
MR Sydes, MR Spears, MD Mason, NW Clarke, DP Dearnaley, ...
Annals of Oncology 29 (5), 1235-1248, 2018
1332018
Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer: data from patients in the control arm of the STAMPEDE trial
ND James, MR Spears, NW Clarke, DP Dearnaley, MD Mason, CC Parker, ...
JAMA oncology 2 (3), 348-357, 2016
1322016
How well prepared are medical students for their first year as doctors? The views of consultants and specialist registrars in two teaching hospitals
C Matheson, D Matheson
Postgraduate Medical Journal 85 (1009), 582-589, 2009
1042009
Addition of docetaxel to hormonal therapy in low-and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
NW Clarke, A Ali, FC Ingleby, A Hoyle, CL Amos, G Attard, CD Brawley, ...
Annals of Oncology 30 (12), 1992-2003, 2019
852019
An introduction to the study of education
D Matheson
Routledge, 2014
802014
An introduction to the study of education
D Matheson
Routledge, 2014
802014
Abiraterone in “high-” and “low-risk” metastatic hormone-sensitive prostate cancer
AP Hoyle, A Ali, ND James, A Cook, CC Parker, JS de Bono, G Attard, ...
European urology 76 (6), 719-728, 2019
622019
Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial
G Attard, MR Sydes, MD Mason, NW Clarke, D Aebersold, JS de Bono, ...
European urology, 2014
602014
Lifelong learning and lifelong education: A critique
D Matheson, C Matheson
Research in Post‐Compulsory Education 1 (2), 219-236, 1996
441996
Adding celecoxib with or without zoledronic acid for hormone-na´ve prostate cancer: long-term survival results from an adaptive, multiarm, multistage, platform, randomizedá…
MD Mason, NW Clarke, ND James, DP Dearnaley, MR Spears, ...
Journal of clinical oncology 35 (14), 1530, 2017
392017
Languages of Scotland: Culture and the classroom
C Matheson, D Matheson
Comparative Education 36 (2), 211-221, 2000
352000
Effects of abiraterone acetate plus prednisone/prednisolone in high and low risk metastatic hormone sensitive prostate cancer
AP Hoyle, SA Ali, ND James, CC Parker, AD Cook, G Attard, ...
Annals of Oncology 29, viii722, 2018
282018
Educational issues in the learning age
D Matheson, C Matheson
Bloomsbury Publishing, 2000
242000
1 What is education?
D Matheson
An introduction to the study of education, 2014
222014
The views of doctors in their first year of medical practice on the lasting impact of a preparation for house officer course they undertook as final year medical students
CB Matheson, DJ Matheson, JH Saunders, C Howarth
BMC medical education 10 (1), 1-9, 2010
222010
Adding abiraterone for men with high-risk prostate cancer (PCa) starting long-term androgen deprivation therapy (ADT): Survival results from STAMPEDE (NCT00268476).
ND James, JS De Bono, MR Spears, N Clarke, MD Mason, DP Dearnaley, ...
Journal of Clinical Oncology 35 (18_suppl), LBA5003-LBA5003, 2017
212017
The system can't perform the operation now. Try again later.
Articles 1–20